Allele-specific induction of IL1B -31 T/C promoter polymorphism by lung carcinogens

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 656, Issue 1-2, 2008, Pages 14-18

  Hart, Kent ^a   Haugen, Aage ^a   Zienolddiny, Shanbeh ^a  

^a NATIONAL INSTITUTE OF OCCUPATIONAL HEALTH   (Norway)

Author keywords

B a P; CSC; IL1B; Lung; Polymorphism; SNP

Indexed keywords

BENZO[A]PYRENE; CARCINOGEN; CIGARETTE SMOKE; DNA; INTERLEUKIN 1BETA; LUCIFERASE;

ALLELE; ARTICLE; BIOINFORMATICS; CHEMICAL CARCINOGENESIS; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DNA POLYMORPHISM; GENE INDUCTION; GENETIC TRANSFECTION; GENETIC VARIABILITY; HUMAN; HUMAN CELL; LUNG CANCER; LUNG CARCINOGENESIS; NUCLEOTIDE BINDING SITE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DNA INTERACTION; WILD TYPE;

ALLELES; BENZO(A)PYRENE; CARCINOGENS; CELL LINE; GENE EXPRESSION REGULATION; GENOTYPE; HUMANS; INTERLEUKIN-1BETA; LUNG; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; TOBACCO; TRANSFECTION;

EID: 53249091930     PISSN: 13835718     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrgentox.2008.06.013     Document Type: Article

References (34)

1. Smith C.J., Perfetti T.A., and King J.A. Perspectives on pulmonary inflammation and lung cancer risk in cigarette smokers. Inhal. Toxicol. 18 (2006) 667-677
2. Azad N., Rojanasakul Y., and Vallyathan V. Inflammation and lung cancer: roles of reactive oxygen/nitrogen species. J. Toxicol. Environ. Health B: Crit. Rev. 11 (2008) 1-15
3. Coussens L.M., and Werb Z. Inflammation and cancer. Nature 420 (2002) 860-867
4. Mantovani A. Cancer: inflammation by remote control. Nature 435 (2005) 752-753
5. Porta C., Subhra K.B., Larghi P., Rubino L., Mancino A., and Sica A. Tumor promotion by tumor-associated macrophages. Adv. Exp. Med. Biol. 604 (2007) 67-86
6. Apte R.N., Krelin Y., Song X., Dotan S., Recih E., Elkabets M., Carmi Y., Dvorkin T., White R.M., Gayvoronsky L., Segal S., and Voronov E. Effects of micro-environment- and malignant cell-derived interleukin-1 in carcinogenesis, tumour invasiveness and tumour-host interactions. Eur. J. Cancer 42 (2006) 751-759
7. Dinarello C.A. Biologic basis for interleukin-1 in disease. Blood 87 (1996) 2095-2147
8. Hellermann G.R., Nagy S.B., Kong X., Lockey R.F., and Mohapatra S.S. Mechanism of cigarette smoke condensate-induced acute inflammatory response in human bronchial epithelial cells. Respir. Res. 3 (2002) 22
9. Krelin Y., Voronov E., Dotan S., Elkabets M., Reich E., Fogel M., Huszar M., Iwakura Y., Segal S., Dinarello C.A., and Apte R.N. Interleukin-1beta-driven inflammation promotes the development and invasiveness of chemical carcinogen-induced tumors. Cancer Res. 67 (2007) 1062-1071
10. Apte R.N., Dotan S., Elkabets M., White M.R., Reich E., Carmi Y., Song X., Dvozkin T., Krelin Y., and Voronov E. The involvement of IL-1 in tumorigenesis, tumor invasiveness, metastasis and tumor-host interactions. Cancer Metast. Rev. 25 (2006) 387-408
11. Shirakawa F., Saito K., Bonagura C.A., Galson D.L., Fenton M.J., Webb A.C., and Auron P.E. The human prointerleukin 1 beta gene requires DNA sequences both proximal and distal to the transcription start site for tissue-specific induction. Mol. Cell Biol. 13 (1993) 1332-1344
12. Lind H., Zienolddiny S., Ryberg D., Skaug V., Phillips D.H., and Haugen A. Interleukin 1 receptor antagonist gene polymorphism and risk of lung cancer: a possible interaction with polymorphisms in the interleukin 1 beta gene. Lung Cancer 50 (2005) 285-290
13. Zienolddiny S., Ryberg D., Maggini V., Skaug V., Canzian F., and Haugen A. Polymorphisms of the interleukin-1 beta gene are associated with increased risk of non-small cell lung cancer. Int. J. Cancer 109 (2004) 353-356
14. Chen H., Wilkins L.M., Aziz N., Cannings C., Wyllie D.H., Bingle C., Rogus J., Beck J.D., Offenbacher S., Cork M.J., Rafie-Kolpin M., Hsieh C.M., Kornman K.S., and Duff G.W. Single nucleotide polymorphisms in the human interleukin-1B gene affect transcription according to haplotype context. Hum. Mol. Genet. 15 (2006) 519-529
15. Haukim N., Bidwell J.L., Smith A.J., Keen L.J., Gallagher G., Kimberly R., Huizinga T., McDermott M.F., Oksenberg J., McNicholl J., Pociot F., Hardt C., and D'Alfonso S. Cytokine gene polymorphism in human disease: on-line databases, supplement 2. Genes Immun. 3 (2002) 313-330
16. Bidwell J., Keen L., Gallagher G., Kimberly R., Huizinga T., McDermott M.F., Oksenberg J., McNicholl J., Pociot F., Hardt C., and D'Alfonso S. Cytokine gene polymorphism in human disease: on-line databases. Genes Immun. 1 (1999) 3-19
17. El-Omar E.M., Carrington M., Chow W.H., McColl K.E., Bream J.H., Young H.A., Herrera J., Lissowska J., Yuan C.C., Rothman N., Lanyon G., Martin M., Fraumeni Jr. J.F., and Rabkin C.S. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 404 (2000) 398-402
18. Wobbe C.R., and Struhl K. Yeast and human TATA-binding proteins have nearly identical DNA sequence requirements for transcription in vitro. Mol. Cell Biol. 10 (1990) 3859-3867
19. Lind H., Haugen A., and Zienolddiny S. Differential binding of proteins to the IL1B -31 T/C polymorphism in lung epithelial cells. Cytokine 38 (2007) 43-48
20. Messeguer X., Escudero R., Farre D., Nunez O., Martinez J., and Alba M.M. PROMO: detection of known transcription regulatory elements using species-tailored searches. Bioinformatics 18 (2002) 333-334
21. Farre D., Roset R., Huerta M., Adsuara J.E., Rosello L., Alba M.M., and Messeguer X. Identification of patterns in biological sequences at the ALGGEN server: PROMO and MALGEN. Nucleic Acids Res. 31 (2003) 3651-3653
22. Takizawa H. Bronchial epithelial cells in allergic reactions. Curr. Drug. Targets Inflamm. Allergy 4 (2005) 305-311
23. Takizawa H. Airway epithelial cells as regulators of airway inflammation (review). Int. J. Mol. Med. 1 (1998) 367-378
24. Anto R.J., Mukhopadhyay A., Shishodia S., Gairola C.G., and Aggarwal B.B. Cigarette smoke condensate activates nuclear transcription factor-kappaB through phosphorylation and degradation of IkappaB(alpha): correlation with induction of cyclooxygenase-2. Carcinogenesis 23 (2002) 1511-1518
25. Shishodia S., and Aggarwal B.B. Cyclooxygenase (COX)-2 inhibitor celecoxib abrogates activation of cigarette smoke-induced nuclear factor (NF)-kappaB by suppressing activation of IkappaBalpha kinase in human non-small cell lung carcinoma: correlation with suppression of cyclin D1, COX-2, and matrix metalloproteinase-9. Cancer Res. 64 (2004) 5004-5012
26. Shishodia S., Potdar P., Gairola C.G., and Aggarwal B.B. Curcumin (diferuloylmethane) down-regulates cigarette smoke-induced NF-kappaB activation through inhibition of IkappaBalpha kinase in human lung epithelial cells: correlation with suppression of COX-2, MMP-9 and cyclin D1. Carcinogenesis 24 (2003) 1269-1279
27. Zhao J., Harper R., Barchowsky A., and Di Y.P. Identification of multiple MAPK-mediated transcription factors regulated by tobacco smoke in airway epithelial cells. Am. J. Physiol. Lung Cell Mol. Physiol. 293 (2007) L480-L490
28. Luppi F., Aarbiou J., van W.S., Rahman I., de Boer W.I., Rabe K.F., and Hiemstra P.S. Effects of cigarette smoke condensate on proliferation and wound closure of bronchial epithelial cells in vitro: role of glutathione. Respir. Res. 6 (2005) 140
29. Perez D.S., Handa R.J., Yang R.S., and Campain J.A. Gene expression changes associated with altered growth and differentiation in benzo[a]pyrene or arsenic exposed normal human epidermal keratinocytes. J. Appl. Toxicol. 28 (2008) 491-508
30. van Leeuwen D.M., Gottschalk R.W., van Herwijnen M.H., Moonen E.J., Kleinjans J.C., and van Delft J.H. Differential gene expression in human peripheral blood mononuclear cells induced by cigarette smoke and its constituents. Toxicol. Sci. 86 (2005) 200-210
31. Joo M., Wright J.G., Hu N.N., Sadikot R.T., Park G.Y., Blackwell T.S., and Christman J.W. Yin Yang 1 enhances cyclooxygenase-2 gene expression in macrophages. Am. J. Physiol. Lung Cell Mol. Physiol. 292 (2007) L1219-L1226
32. Thomas M.J., and Seto E. Unlocking the mechanisms of transcription factor YY1: are chromatin modifying enzymes the key?. Gene 236 (1999) 197-208
33. Ito K., Charron C.E., and Adcock I.M. Impact of protein acetylation in inflammatory lung diseases. Pharmacol. Ther. 116 (2007) 249-265
34. Hasselgren P.O. Ubiquitination, phosphorylation, and acetylation-triple threat in muscle wasting. J. Cell Physiol. 213 (2007) 679-689